19:07 GMT16 January 2021
Listen Live
    Get short URL

    China’s next-generation gene sequencing technology has achieved breakthroughs and now leads the world, the country's National Development and Reform Commission said via its official WeChat account on Oct. 9.

    In just five years, highly accurate and affordable gene testing has been embraced by more and more people in China, and the market for this service could reach 6 billion yuan (around $911 million) in 2016, which is more than five times than that in 2012, topping the world with its annual compound growth rate of 50 percent.

    Chinese companies and research institutions have broken the monopoly on sequencing devices and reagent manufacturing by independently developing BIGIS, the first second-generation sequencers in China. Some types of domestic sequencers have been approved by the China Food and Drug Administration to enter the market.

    Moreover, BGI, a domestic frontier life science institution and a leader in the field of gene sequencing in China, has developed DNA-based single-cell sequencing technology, indicating that China has started research on third-generation sequencing technology.

    China's fast development of gene science has been one of the main achievements in the hi-tech field since the 18th National Congress of the Communist Party of China. Now the gene industry has been a driving force for China’s economic growth and attracting a high amount of attention from the capital markets.

    (The story is also published on People’s Daily Online)

    This article was originally published in Huanqiu.


    China Becomes World's Second Largest Medicine Consumer
    A Taste of Their Own Medicine: China Blames US for Aiding Global Cyber Attacks
    China to Allocate Georgia Over $9Mln for Medicine Development
    China launches new swine flu medicine that cures in 3 days
    gene, technology, science, DNA, China
    Community standardsDiscussion